Indication
Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques. In clinical trials, Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- CetrotideBrazil · Merck S/ASame brand
- CetrotideBrazil · Serono Produtos Farmacêuticos LtdaSame brand
- CetrotideCanada · 0.25 MG / VIAL · Powder For Solution · Emd Serono, A Division of Emd INC., CanadaSame brand
- CetrotideCanada · 3 MG / VIAL · Powder For Solution · Emd Serono, A Division of Emd INC., CanadaSame brand